Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/6418

2-Methylimidazole: Target Organs and Levels of Evidence for TR-516

Toxicology and Carcinogenesis Studies of 2-Methylimidazole (CASRN 693-98-1) in F344/N Rats and B6C3F1 Mice (Feed Studies)

Chemical (Study Title)
CASRN
Peer Review DateRoute/Exposure LevelsStudy Laboratory
2-Methylimidazole
693-98-1
05/22/2003Dosed-Feed
MR: 0, 300, 1000, OR 3000 PPM; FR: 0, 1000, 2500, OR 5000 PPM; M: 0, 625, 1250, OR 2500 PPM; 60/SEX/SPECIES/GROUP
Southern Research Institute

Levels of Evidence

Male Rats: Some Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Thyroid Gland Follicular Cell: ADENOMA OR CARCINOMA 1/48 2/46 1/43 5/50
May Have Been Related
  • Liver: ADENOMA OR CARCINOMA 0/50 1/50 3/50 3/50
Non-Neoplastic Lesions
  • THYROID GLAND: FOLLICULAR CELL HYPERPLASIA
  • LIVER: MIXED CELL FOCUS
Female Rats: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Thyroid Gland Follicular Cell: ADENOMA 0/49 0/48 0/42 5/48 CARCINOMA 1/49 1/48 1/42 7/48 COMBINED 1/49 1/48 1/42 11/48
May Have Been Related
  • Liver: ADENOMA 1/50 0/49 2/50 4/50
Non-Neoplastic Lesions
  • THYROID GLAND: FOLLICULAR CELL HYPERPLASIA; MINERALIZATION
  • LIVER: BILE DUCT HYPERPLASIA; GRANULOMATOUS INFLAMMATION; MIXED CELL FOCUS
  • SPLEEN: GRANULOMATOUS INFLAMMATION
Male Mice: Some Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Thyroid Gland Follicular Cell: ADENOMA 0/50 1/50 0/50 7/50
  • Liver: ADENOMA 7/50 14/50 13/50 18/50 CARCINOMA 4/50 8/50 14/50 6/50 COMBINED 10/50 22/50 22/50 22/50
Non-Neoplastic Lesions
  • THYROID GLAND: FOLLICULAR CELL HYPERPLASIA; FOLLICULAR CELL HYPERTROPHY
  • LIVER: HEPATOCYTE CYTOPLASMIC ALTERATION; HEPATOCYTE KARYOMEGALY; KUPFFER CELL PIGMENTATION
  • SPLEEN: HEMATOPOIETIC CELL PROLIFERATION; PIGMENTATION; LYMPHOID FOLLICLE ATROPHY
  • BONE MARROW: HYPERPLASIA
  • KIDNEY: PIGMENTATION
  • EPIDIDYMIS: CHRONIC ACTIVE INFLAMMATION; SPERM GRANULOMA
  • TESTES: GERMINAL EPITHELIAL ATROPHY
Female Mice: Some Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Liver: ADENOMA 3/50 4/49 6/49 10/50
Non-Neoplastic Lesions
  • THYROID GLAND: FOLLICULAR CELL HYPERPLASIA; FOLLICULAR CELL HYPERTROPHY
  • SPLEEN: HEMATOPOIETIC CELL PROLIFERATION; PIGMENTATION